H4: the lot was manufactured from february 17, 2021 - february 18, 2021.The device was received for evaluation.A visual inspection was performed which revealed a brown residue within the extension set.The brown residue was forwarded to the particles and interfaces lab for identification.Stereomicroscopic examination revealed the residue consist of a brown amorphous material.Chemical characterization using fourier transform infrared spectroscopy (ftir) determined the brown residue was composed of a secondary amide material.Micro-chemical analysis revealed a presence of blood in the brown residue.The brown residue was fount to be blood from the patient.The reported condition was verified.The cause of the condition could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|